Literature DB >> 27867633

A crucial first randomized controlled trial of thymectomy in non-thymomatous myasthenia gravis.

Pierre R Bourque1, Jodi Warman Chardon2.   

Abstract

Entities:  

Year:  2016        PMID: 27867633      PMCID: PMC5107546          DOI: 10.21037/jtd.2016.10.15

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  16 in total

1.  Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  G S Gronseth; R J Barohn
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

2.  Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity.

Authors:  R S Bedlack; D L Simel; H Bosworth; G Samsa; B Tucker-Lipscomb; D B Sanders
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

3.  MYASTHENIA GRAVIS AND TUMORS OF THE THYMIC REGION: REPORT OF A CASE IN WHICH THE TUMOR WAS REMOVED.

Authors:  A Blalock; M F Mason; H J Morgan; S S Riven
Journal:  Ann Surg       Date:  1939-10       Impact factor: 12.969

4.  Treatment and clinical research in myasthenia gravis: how far have we come?

Authors:  Richard J Barohn
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

5.  Long-lasting treatment effect of rituximab in MuSK myasthenia.

Authors:  J Díaz-Manera; E Martínez-Hernández; L Querol; R Klooster; R Rojas-García; X Suárez-Calvet; J L Muñoz-Blanco; C Mazia; K R Straasheijm; E Gallardo; C Juárez; J J Verschuuren; I Illa
Journal:  Neurology       Date:  2012-01-04       Impact factor: 9.910

6.  Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study.

Authors:  Matthew N Meriggioli; Julie Rowin; Judith G Richman; Sue Leurgans
Journal:  Ann N Y Acad Sci       Date:  2003-09       Impact factor: 5.691

Review 7.  Thymectomy for nonthymomatous myasthenia gravis: a critical analysis.

Authors:  Joshua R Sonett; Alfred Jaretzki
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

8.  Alternate-day prednisone: preliminary report of a double-blind controlled study.

Authors:  F M Howard; D D Duane; E H Lambert; J R Daube
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

9.  Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.

Authors:  Adam Bryant; Harold Atkins; C Elizabeth Pringle; David Allan; Grizel Anstee; Isabelle Bence-Bruckler; Linda Hamelin; Michael Hodgins; Harry Hopkins; Lothar Huebsch; Sheryl McDiarmid; Mitchell Sabloff; Dawn Sheppard; Jason Tay; Christopher Bredeson
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

10.  Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study.

Authors:  P R Bourque; C E Pringle; W Cameron; J Cowan; J Warman Chardon
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

View more
  2 in total

1.  Randomized trial of thymectomy in myasthenia gravis.

Authors:  Gil I Wolfe; Henry J Kaminski; Joshua R Sonnett; Inmaculada B Aban; Hui-Chien Kuo; Gary R Cutter
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Thymectomy in Non-Thymomatous Myasthenia Gravis: Does An RCT Solve The 75-Year-Old Controversy?

Authors:  Nishita Singh; Vinay Goyal
Journal:  Ann Indian Acad Neurol       Date:  2019-12-18       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.